Phase behavior, intermolecular interaction, and solid state characterization of amorphous solid dispersion of Febuxostat

References

• Kogermann K, Penkina A, Predbannikova K, et al. Dissolution testing of amorphous solid dispersions. Int J Pharm 2013;444:40–46.
   PubMed Web of Science ®Google Scholar
• Konno H, Taylor LS. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J Pharm Sci 2006;95:2692–2705.
   PubMed Web of Science ®Google Scholar
• Aso Y, Yoshioka S, Kojima S. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions. J Pharm Sci 2004;93:384–391.
   PubMed Web of Science ®Google Scholar
• Gupta P, Kakumanu VK, Bansal AK. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm Res 2004;21:1762–1769.
   PubMed Web of Science ®Google Scholar
• Kakumanu VK, Bansal AK. Enthalpy relaxation studies of celecoxib amorphous mixtures. Pharm Res 2002;19:1873–1878.
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Yoshioka S, Aso Y, Kojima S. Ability of polyvinylpyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen. J Pharm Sci 2004;93:2710–2717.
   PubMed Web of Science ®Google Scholar
• Marsac PJ, Konno H, Taylor LS. A comparison of the physical stability of amorphous felodipine and nifedipine systems. Pharm Res 2006;23:2306–2316.
   PubMed Web of Science ®Google Scholar
• Yoshioka M, Hancock BC, Zografi G. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature. J Pharm Sci 1994;83:1700–1705.
   PubMed Web of Science ®Google Scholar
• Hancock BC, Shamblin SL, Zografi G. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharm Res 1995;12:799–806.
   PubMed Web of Science ®Google Scholar
• Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today 2007;12:1068–1075.
   PubMed Web of Science ®Google Scholar
• Dukeck R, Sieger P, Karmwar P. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective. Eur J Pharm Sci 2013;49:723–731.
   PubMed Web of Science ®Google Scholar
• Patel RP, Patel DJ, Bhimani DB, Patel JK. Physicochemical characterization and dissolution study of solid dispersions of furosemide with polyethylene glycol 6000 and polyvinylpyrrolidone K30. Dissol Technol 2008;15:17–25.
   Web of Science ®Google Scholar
• Huang Y, Dai W-G. Fundamental aspects of solid dispersion technology for poorly soluble drugs. Acta Pharm Sinica B 2014;4:18–25.
   PubMed Web of Science ®Google Scholar
• Konno H, Handa T, Alonzo DE, Taylor LS. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. Eur J Pharm Biopharm 2008;70:493–499.
   PubMed Web of Science ®Google Scholar
• Castellanos A. The relationship between attractive interparticle forces and bulk behaviour in dry and uncharged fine powders. Adv Phys 2005;54:263–376.
   Web of Science ®Google Scholar
• Van den Mooter G, Wuyts M, Blaton N, et al. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci 2001;12:261–269.
   PubMed Web of Science ®Google Scholar
• Taylor LS, Langkilde FW, Zografi G. Fourier transform Raman spectroscopic study of the interaction of water vapor with amorphous polymers. J Pharm Sci 2001;90:888–901.
   PubMed Web of Science ®Google Scholar
• Taylor LS, Zografi G. Sugar-polymer hydrogen bond interactions in lyophilized amorphous mixtures. J Pharm Sci 1998;87:1615–1621.
   PubMed Web of Science ®Google Scholar
• Taylor LS, Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res 1997;14:1691–1698.
   PubMed Web of Science ®Google Scholar
• Gupta P, Bansal AK. Ternary amorphous composites of celecoxib, poly(vinyl pyrrolidone) and meglumine with enhanced solubility. Pharmazie 2005;60:830–836.
   PubMed Web of Science ®Google Scholar
• Bansal SS, Kaushal AM, Bansal AK. Molecular and thermodynamic aspects of solubility advantage from solid dispersions. Mol Pharm 2007;4:794–802.
   PubMed Web of Science ®Google Scholar
• Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 1997;86:1–12.
   PubMed Web of Science ®Google Scholar
• Caron V, Tajber L, Corrigan OI, Healy AM. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone. Mol Pharm 2011;8:532–542.
   PubMed Web of Science ®Google Scholar
• Qian KK, Bogner RH. Spontaneous crystalline-to-amorphous phase transformation of organic or medicinal compounds in the presence of porous media, part 1: thermodynamics of spontaneous amorphization. J Pharm Sci 2011;100:2801–2815.
   PubMed Web of Science ®Google Scholar
• Couchman PR, Karasz FE. A classical thermodynamic discussion of the effect of composition on glass-transition temperatures. Macromolecules 1978;11:117–119.
   Web of Science ®Google Scholar
• Gordon M, Taylor JS. Ideal copolymers and the second-order transitions of synthetic rubbers. i. non-crystalline copolymers. J Appl Chem 1952;2:493–500.
   Web of Science ®Google Scholar
• Bakule R, Biros J, Fähnrich J. A calorimetric study of the glass transition kinetics in polyisoprene. Colloid Polym Sci 1991;269:665–674.
   Web of Science ®Google Scholar
• Brekner M-J, Schneider HA, Cantow H-J. Approach to the composition dependence of the glass transition temperature of compatible polymer blends, 2. The effect of local chain orientation. Die Makromolekulare Chemie 1988;189:2085–2097.
   Web of Science ®Google Scholar
• Brostow W, Chiu R, Kalogeras IM, Vassilikou-Dova A. Prediction of glass transition temperatures: binary blends and copolymers. Mater Lett 2008;62:3152–3155.
   Web of Science ®Google Scholar
• Panayiotou CG. Glass transition temperatures in polymer mixtures. Polym J 1986;18:895–902.
   Web of Science ®Google Scholar
• Lee J-C, Litt MH. Glass transition temperature-composition relationship of oxyethylene copolymers with chloromethyl/(ethylthio)methyl, chloromethyl/(ethylsulfinyl)methyl, or chloromethyl/(ethylsulfonyl)methyl side groups. Polym J 2000;32:228–233.
   Web of Science ®Google Scholar
• Couchman PR. Glass-transition temperatures of compatible polymer mixtures. Phys Lett A 1979;70:155–157.
   Web of Science ®Google Scholar
• Kwei TK. The effect of hydrogen bonding on the glass transition temperatures of polymer mixtures. J Polym Sci 1984;22:307–313.
   Web of Science ®Google Scholar
• Baird JA, Taylor LS. Evaluation of amorphous solid dispersion properties using thermal analysis techniques. Adv Drug Deliv Rev 2012;64:396–421.
   PubMed Web of Science ®Google Scholar
• Gupta P, Thilagavathi R, Chakraborti AK, Bansal AK. Role of molecular interaction in stability of celecoxib-PVP amorphous systems. Mol Pharm 2005;2:384–391.
   PubMed Web of Science ®Google Scholar
• Cilurzo F, Minghetti P, Casiraghi A, Montanari L. Characterization of nifedipine solid dispersions. Int J Pharm 2002;242:313–317.
   PubMed Web of Science ®Google Scholar
• Six K, Verreck G, Peeters J, et al. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast‐and slow‐dissolving polymers. J Pharm Sci 2004;93:124–131.
   PubMed Web of Science ®Google Scholar
• Khougaz K, Clas SD. Crystallization inhibition in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymers. J Pharm Sci 2000;89:1325–1334.
   PubMed Web of Science ®Google Scholar
• Maddileti D, Jayabun S, Nangia A. Soluble cocrystals of the xanthine oxidase inhibitor Febuxostat. Cryst Growth Des 2013;13:3188–3196.
   Web of Science ®Google Scholar
• Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm 2004;272:1–10.
   PubMed Web of Science ®Google Scholar
• Zhang M, Li H, Lang B, et al. Formulation and delivery of improved amorphous fenofibrate solid dispersions prepared by thin film freezing. Eur J Pharm Biopharm 2012;82:534–544.
   PubMed Web of Science ®Google Scholar
• Weuts I, Kempen D, Decorte A, et al. Phase behaviour analysis of solid dispersions of loperamide and two structurally related compounds with the polymers PVP-K30 and PVP-VA64. Eur J Pharm Sci 2004;22:375–385.
   PubMed Web of Science ®Google Scholar
• Pavia DL, Lampman GM, Kriz GS, Vyvyan JR. Introduction to spectroscopy, 4th ed. Belmont: Brooks/Cole Cengage Learning; 2001:15–104.
   Google Scholar